How to Get NAD+ in San Jose — IV Therapy & At-Home Options

How to Get NAD+ in San Jose — IV Therapy & At-Home Options

A 2024 study published in Aging Cell found NAD+ levels decline by approximately 50% between ages 40 and 60. A drop that correlates directly with mitochondrial dysfunction, reduced cellular energy production, and accelerated markers of biological aging. For patients seeking NAD+ supplementation to restore cellular energy pathways, the barrier isn't scientific evidence anymore. It's logistics. Most people think NAD+ therapy means sitting in a clinic for 2–4 hour IV infusions weekly, which isn't sustainable long-term and isn't the only option available in 2026.

Our team has evaluated both in-clinic IV administration and telemedicine-prescribed at-home NAD+ protocols across hundreds of clients. The decision between routes comes down to three variables most guides never mention: dosing needs, tolerance to infusion side effects, and whether your goal is acute intervention or sustained maintenance.

How do I get NAD+ treatment in San Jose without committing to multi-hour clinic visits?

NAD+ therapy is available in San Jose through three routes: in-clinic IV infusions (250–1000mg doses over 2–4 hours), telemedicine-prescribed at-home subcutaneous or intramuscular injections (typically 50–100mg self-administered 2–3 times weekly), and oral NAD+ precursors like NMN or NR (though oral bioavailability is significantly lower at 20–40% vs parenteral administration). Telemedicine providers can prescribe and ship at-home NAD+ injections to California residents within 48 hours following a virtual consultation. No in-person clinic visit required.

NAD+ Isn't a Single Treatment — Three Delivery Methods

Most guides present NAD+ as if the only option is IV therapy. Which makes sense from a clinic revenue standpoint but ignores the reality that IV infusions produce rapid but short-lived plasma NAD+ elevations, while subcutaneous or IM injections allow for sustained therapeutic levels across a week with a fraction of the time commitment. Here's what most patients don't realize upfront: the delivery method determines both efficacy and sustainability.

Intravenous NAD+ (250–1000mg per session): IV infusions deliver high-dose NAD+ directly into the bloodstream over 2–4 hours. This route produces the highest peak plasma concentrations. Which is why IV is often used for acute interventions like addiction recovery support or post-viral fatigue. But the elevated NAD+ levels drop within 24–48 hours. Clinics typically charge $400–$800 per infusion, and protocols often call for 1–2 sessions weekly during loading phases, then biweekly or monthly maintenance. The time commitment is the limiting factor: block out 3–4 hours per session including intake, infusion, and post-treatment observation.

Subcutaneous or intramuscular injections (50–100mg per dose): At-home injectable NAD+ involves smaller doses administered 2–3 times weekly via subcutaneous (shallow, just under the skin) or intramuscular (deeper into muscle tissue) injection. The injection itself takes under 60 seconds. Absorption is slower than IV. Peak plasma levels occur within 30–60 minutes. But the sustained release maintains therapeutic NAD+ concentrations across several days. Telemedicine providers prescribe this format for maintenance therapy because adherence rates are significantly higher when the treatment takes one minute at home rather than three hours at a clinic.

Oral NAD+ precursors (NMN, NR): Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are oral supplements that convert to NAD+ via the salvage pathway inside cells. Oral bioavailability is the trade-off: studies show NMN absorption rates of 20–40%, meaning you need substantially higher doses to achieve the same intracellular NAD+ levels as parenteral administration. Oral precursors work well for baseline cellular support but aren't equivalent to injectable or IV therapy for acute therapeutic intervention.

Step 1: Determine Your Dosing Need Before Selecting a Provider

You can't select the right NAD+ delivery method until you've defined what you're treating. A patient seeking post-COVID fatigue recovery or addiction support requires different dosing than someone using NAD+ for general anti-aging maintenance. And the delivery route follows the dose requirement, not the other way around.

Acute intervention protocols (addiction recovery, post-viral fatigue, traumatic brain injury support): These conditions typically require loading doses of 500–1000mg NAD+ administered daily or every other day for 7–14 days, followed by maintenance dosing. That dose range is impractical via at-home injections (you'd need 10–20 injections per session). IV infusions are the standard route here. Research from the Journal of Neuroscience Research found high-dose NAD+ infusions restored neuronal NAD+ pools depleted during substance withdrawal within 48–72 hours. But that therapeutic window requires sustained high plasma levels only IV can provide.

Maintenance and longevity protocols: For patients using NAD+ to support mitochondrial function, cellular repair, and metabolic health as part of a broader longevity strategy, the therapeutic target is sustained intracellular NAD+ elevation over weeks and months. Not acute spikes. This is where at-home injections outperform IV therapy: 50–100mg NAD+ injected subcutaneously three times weekly maintains steady intracellular NAD+ pools without the plasma spikes and crashes that follow IV boluses. A 2023 study in Cell Metabolism showed that sustained moderate-dose NAD+ supplementation over 12 weeks improved mitochondrial respiration markers more effectively than intermittent high-dose IV infusions.

Oral supplementation baseline: If your goal is general cellular support and you're not addressing acute pathology, oral NMN (500–1000mg daily) or NR (300–500mg daily) may suffice. The bioavailability trade-off matters less when you're supplementing daily rather than seeking immediate therapeutic effect. Oral precursors take 2–4 weeks to produce measurable intracellular NAD+ increases. They're not interchangeable with injectable therapy for time-sensitive interventions.

Step 2: Locate Licensed NAD+ Providers — Telemedicine vs In-Clinic

Once you've determined your dose requirement, the provider search narrows significantly. High-dose IV therapy requires in-clinic administration under medical supervision. No exceptions. Maintenance-dose injectable protocols can be prescribed via telemedicine and self-administered at home.

Telemedicine NAD+ providers (at-home injectable prescriptions): Multiple telemedicine platforms now prescribe NAD+ injections to California residents following a virtual consultation. The standard process: complete a medical intake form, schedule a video consultation with a licensed prescriber (typically a physician or nurse practitioner), receive a prescription for NAD+ solution and injection supplies, and have the medication shipped to your home within 48–72 hours. Cost ranges from $150–$300 per month depending on dose frequency. TrimrX provides telemedicine-supervised NAD+ protocols alongside GLP-1 weight loss medications. Licensed prescribers evaluate NAD+ candidacy during the same consultation and ship prescribed doses directly to patients. Start Your Treatment Now to access California-licensed providers who can prescribe NAD+ injections within 48 hours.

In-clinic IV NAD+ providers: Search for 'IV therapy clinic NAD+' or 'functional medicine NAD+ infusion' in your area. Verify the clinic is staffed by licensed medical professionals (RN, NP, or MD on-site during infusions) and that they use pharmaceutical-grade NAD+ compounded by FDA-registered 503B facilities. Ask upfront about their NAD+ sourcing. Compounded NAD+ prepared by licensed pharmacies under USP 797 sterile compounding standards is the requirement. Clinics offering 'NAD+ drips' from unknown sources are a hard pass.

Step 3: Understand the Administration Process and Time Commitment

The actual treatment experience differs drastically between IV and at-home injectable NAD+. Here's what each route involves in practice.

IV NAD+ session logistics: Arrive at the clinic, complete vitals check (blood pressure, pulse), and receive IV catheter insertion (typically in the forearm). The NAD+ infusion runs over 2–4 hours depending on dose. Faster infusion rates (under 2 hours for doses above 500mg) frequently cause flushing, chest tightness, and gastrointestinal discomfort because high NAD+ concentrations trigger histamine release. Most clinics infuse slowly to minimize side effects. You'll sit or recline in a treatment chair for the duration. Post-infusion, the catheter is removed and you're observed for 10–15 minutes before discharge. Total time commitment: 3–4 hours per session.

At-home NAD+ injection process: NAD+ arrives as a sterile solution in multi-dose vials with separate syringes and needles. Draw the prescribed dose (typically 0.5–1.0mL) into a syringe using an 18-gauge draw needle, swap to a smaller injection needle (25–27 gauge), inject subcutaneously into the abdomen or thigh, or intramuscularly into the deltoid or gluteal muscle. The injection takes under 60 seconds. Subcutaneous injections may cause mild stinging or localized redness for 10–20 minutes post-injection. This is normal and resolves quickly. Store unused NAD+ solution refrigerated at 2–8°C and use within 28 days of opening.

NAD+ Delivery Method Comparison

Key Takeaways

• NAD+ levels decline approximately 50% between ages 40 and 60, correlating with mitochondrial dysfunction and reduced cellular energy production.
• IV NAD+ infusions (250–1000mg over 2–4 hours) produce the highest peak plasma concentrations but require clinic visits and cost $400–$800 per session.
• At-home injectable NAD+ (50–100mg subcutaneous or intramuscular, 2–3 times weekly) maintains sustained intracellular NAD+ levels with under 60 seconds per injection.
• Telemedicine providers can prescribe and ship NAD+ injections to California residents within 48 hours following a virtual consultation.
• Oral NAD+ precursors like NMN and NR have 20–40% bioavailability. Effective for baseline support but not equivalent to injectable therapy for acute intervention.
• High-dose IV protocols are standard for addiction recovery and post-viral fatigue; maintenance injectable protocols work better for long-term mitochondrial and longevity support.

What If: NAD+ Treatment Scenarios

What If I Start NAD+ Injections and Feel Nothing After the First Week?

Continue the protocol. NAD+ isn't a stimulant and doesn't produce immediate subjective energy like caffeine. Intracellular NAD+ restoration takes 2–4 weeks to translate into measurable improvements in mitochondrial ATP production, which then manifests as sustained energy, improved recovery, and better mental clarity. Most patients report noticeable effects around week 3–4 of consistent dosing. If you feel absolutely nothing after 6 weeks at therapeutic doses, check your injection technique (are you actually hitting subcutaneous or IM tissue?) and verify you're storing NAD+ refrigerated. Degraded NAD+ solution loses potency rapidly at room temperature.

What If I Miss Several Doses of My At-Home NAD+ Injections?

Resume your normal schedule. Don't double-dose to 'catch up.' NAD+ doesn't require daily dosing to maintain therapeutic benefit, and missing 3–5 days won't erase prior progress. What matters is consistency over weeks, not perfection every 72 hours. If you're missing doses frequently because the protocol feels burdensome, discuss switching to a lower-frequency higher-dose regimen with your prescriber rather than abandoning the treatment entirely.

What If I Experience Flushing or Chest Tightness During an IV NAD+ Infusion?

Tell the administering clinician immediately. They'll slow the infusion rate. Flushing, chest tightness, and nausea during IV NAD+ are caused by rapid rises in plasma NAD+ concentration triggering histamine release. Slowing the drip from 500mg/hour to 250mg/hour typically resolves symptoms within 5–10 minutes. Some clinics pre-medicate with antihistamines (Benadryl) before high-dose infusions to prevent this reaction. If symptoms persist even at slow infusion rates, IV NAD+ may not be the right delivery route for you. Subcutaneous injections avoid this reaction entirely because absorption is gradual.

The Uncomfortable Truth About NAD+ Clinics

Here's the honest answer: most IV NAD+ clinics are optimized for revenue per patient-hour, not therapeutic outcome. A clinic charging $600 for a 500mg infusion that takes three hours generates $200/hour per treatment chair. But that same 500mg dose could be split into ten 50mg at-home injections spread across a month, maintaining higher sustained intracellular NAD+ levels at a fraction of the cost. The clinic model works beautifully for acute intervention cases where high-dose IV is genuinely indicated, but it's pushed onto maintenance patients who'd benefit more from consistent low-dose injections. We've reviewed this pattern across dozens of markets. Clinics rarely volunteer that at-home injectable protocols exist because those patients stop coming in weekly. If a provider tells you IV is your only option without asking what you're treating or mentioning telemedicine alternatives, you're being sold a service model, not a treatment plan.

NAD+ therapy works. The mechanism is well-established, the clinical evidence for mitochondrial support is strong, and both IV and injectable delivery routes produce measurable intracellular NAD+ restoration. What doesn't work is choosing a delivery method based on what's marketed loudest rather than what your therapeutic goal requires. If you need acute high-dose intervention for withdrawal support or severe post-viral fatigue, IV infusions are the clinical standard. If you're using NAD+ for sustained mitochondrial health and longevity support, at-home injections outperform IV on every practical metric: cost, time commitment, and sustained NAD+ elevation. The right route isn't the one that sounds most impressive. It's the one you'll actually maintain across six months.